Kevin Rakin's most recent trade in Elutia Inc - Ordinary Shares - Class A was a trade of 90,509 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elutia Inc - Ordinary Shar... | Kevin Rakin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 90,509 | 90,509 | - | - | Stock Option (Right to Buy) | |
| Quantum-Si Incorporated - ... | Kevin Rakin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 126,095 | 126,095 | - | - | Stock Option (right to buy) | |
| Elutia Inc - Ordinary Shar... | Kevin Rakin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 47,753 | 47,753 | - | - | Stock Option (Right to Buy) | |
| Quantum-Si Incorporated - ... | Kevin Rakin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 113,281 | 113,281 | - | - | Stock Option (right to buy) | |
| Quantum-Si Incorporated - ... | Kevin Rakin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 120,481 | 120,481 | - | - | Stock Option (right to buy) | |
| Quantum-Si Incorporated - ... | Kevin Rakin | Director | Other type of transaction at price $ 0.00 per share. | 20 Dec 2022 | 601,000 | 1,200,000 | - | 0 | Class A Common Stock | |
| Quantum-Si Incorporated - ... | Kevin Rakin | Director | Sale of securities on an exchange or to another person at price $ 2.15 per share. | 15 Dec 2022 | 89,000 | 1,801,000 | - | 2.1 | 191,234 | Class A Common Stock |
| Quantum-Si Incorporated - ... | Kevin Rakin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 59,880 | 59,880 | - | - | Stock Option (right to buy) | |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 21 Mar 2022 | 10,000 | 46,661 (0%) | 0% | 9.4 | 94,096 | Common Stock |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 6,667 | 0 | - | - | Stock Option (right to buy) | |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.80 per share. | 17 Feb 2022 | 6,667 | 59,671 (0%) | 0% | 4.8 | 32,002 | Common Stock |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.63 per share. | 17 Feb 2022 | 3,010 | 56,661 (0%) | 0% | 10.6 | 31,996 | Common Stock |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Feb 2022 | 5,000 | 53,004 (0%) | 0% | 0 | Common Stock | |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 6,000 | 58,004 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Dec 2021 | 5,000 | 52,004 (0%) | 0% | 0 | Common Stock | |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Sale of securities on an exchange or to another person at price $ 20.99 per share. | 16 Sep 2021 | 21,100 | 57,004 (0%) | 0% | 21.0 | 442,830 | Common Stock |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 10,000 | 78,104 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.77 per share. | 09 Aug 2021 | 56,773 | 89,020 (0%) | 0% | 7.8 | 441,126 | Common Stock |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 56,773 | 0 | - | - | Stock Option (right to buy) | |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. | 09 Aug 2021 | 20,916 | 68,104 (0%) | 0% | 21.1 | 441,118 | Common Stock |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.17 per share. | 09 Aug 2021 | 10,000 | 34,224 (0%) | 0% | 4.2 | 41,700 | Common Stock |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.80 per share. | 09 Aug 2021 | 6,666 | 25,741 (0%) | 0% | 4.8 | 31,997 | Common Stock |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 6,666 | 0 | - | - | Stock Option (right to buy) | |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 5,697 | 0 | - | - | Stock Option (right to buy) | |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.23 per share. | 09 Aug 2021 | 5,697 | 20,758 (0%) | 0% | 6.2 | 35,492 | Common Stock |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. | 09 Aug 2021 | 1,977 | 32,247 (0%) | 0% | 21.1 | 41,695 | Common Stock |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. | 09 Aug 2021 | 1,683 | 19,075 (0%) | 0% | 21.1 | 35,494 | Common Stock |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.09 per share. | 09 Aug 2021 | 1,517 | 24,224 (0%) | 0% | 21.1 | 31,994 | Common Stock |
| Quantum-Si Incorporated - ... | Kevin Rakin | Director | Grant, award, or other acquisition of securities at price $ 10.00 per share. | 10 Jun 2021 | 1,901,000 | 1,901,000 | - | 10 | 19,010,000 | Class A Common Stock |
| Quantum-Si Incorporated - ... | Kevin Rakin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 20,512 | 20,512 | - | 0 | Class A Common Stock | |
| Oramed Pharmaceuticals, Inc | Kevin Rakin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) |